Post Partum Hemorrhage Clinical Trial
Official title:
A Comparative Study Between Cervical Traction and Active Management of 3rd Stage of Labor in Prevention of Postpartum Hemorrhage After Vaginal Delivery
NCT number | NCT04747015 |
Other study ID # | 61 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | July 13, 2020 |
Est. completion date | December 2021 |
306 patients will be divided randomly in to 2 GROUPS: - control group: 153 patients will receive Oxytocin 10 IU I.V shot administered at the time of delivery of the anterior shoulder of the baby for both groups in prevention of postpartum haemorrhage,followed by active management of the third stage of labor by administration of oxytocin 5 IU units IM and waiting for signs of placental separation then controlled cord traction (CCT) to the umbilical cord while applying simultaneous counter-pressure to the uterus, through the abdomen(Brandt Andrews maneuver) - study group:156 patients received Oxytocin 10 IU I.V shot at the time of delivery of the of the anterior shoulder of the baby according to the WHO recommendation .Then oxytocin is stopped and cervical traction (Amr maneuver )is applied. In the maneuver,sustained traction downward and posteriorly was applied to anterior and posterior lips of the cervix using ovum forceps for approximately 90 seconds. The traction should be adequate to allow the cervix to reach the vaginal introitus. Meanwhile (CCT ) is avoided and watchful waiting for signs of placental separartion till 90 seconds end. Massage is not employed but the fundus is frequently palpaple to insure it doesnot become atonic and filled with blood from placenta separation. In cases whom placental separation did not occur within the 90 seconds, we removed the ovum forceps and waited for 30 min for the placental separation .
Status | Recruiting |
Enrollment | 306 |
Est. completion date | December 2021 |
Est. primary completion date | December 2021 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 42 Years |
Eligibility | Inclusion Criteria: singleton pregnancy full term pregnancy ( gestational age 37 - 42 weeks). Exclusion Criteria: - twin pregnancy, preterm labor <36 weeks, fetal macrosomia, any case with bleeding tendency e.g: haemorrhagic diseases and cases with risk of postpartum haemorrhage as: Peripartun hemorrhage ( placenta previa or placental abruption), anemia or hypertension |
Country | Name | City | State |
---|---|---|---|
Egypt | Kasr Alainy medical school | Cairo |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | occurrence of postpartum hemorrhage | blood loss more than 500 ml | 24 hours after delivery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03680339 -
The Effect of Preoperative and Post Operative Misoprostol Administration on Intraoperative Blood Loss and Postpartum Hemorrhage in CS
|
Phase 4 | |
Completed |
NCT03693599 -
Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean
|
Phase 4 | |
Completed |
NCT03707132 -
Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
|
||
Recruiting |
NCT02306733 -
Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally
|
Phase 3 | |
Completed |
NCT01866241 -
Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage
|
Phase 3 | |
Not yet recruiting |
NCT01236482 -
Oxytocin in Cesarean Delivery
|
Phase 4 | |
Completed |
NCT03784794 -
Patient Blood Management for Massive Obstetric Hemorrhage
|
N/A | |
Enrolling by invitation |
NCT06255496 -
QStat Cartridge in Obstetric Patients
|
||
Recruiting |
NCT04401839 -
Amr Maneuver for Prevention of Postpartum Hemorrhage
|
N/A | |
Recruiting |
NCT06219538 -
DAISY Uterine Drain Device Evaluation
|
N/A | |
Not yet recruiting |
NCT06333340 -
Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery
|
N/A | |
Completed |
NCT01863706 -
Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage
|
Phase 1 | |
Completed |
NCT04723979 -
NovoSeven® in Severe Postpartum Haemorrhage - Experiences From UK, DK, FR, NL
|
||
Terminated |
NCT04277962 -
Estimating Blood Loss Using TritonTM in Vaginal Deliveries: A Validation Trial
|
N/A | |
Completed |
NCT03570723 -
Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa
|
N/A | |
Completed |
NCT03117647 -
Mansoura-VV Uterine Compression Suture for Primary Atonic Postpartum Hemorrhage
|
N/A | |
Active, not recruiting |
NCT03069859 -
Use of TXA to Prevent Postpartum Hemorrhage
|
Phase 2 | |
Not yet recruiting |
NCT03891082 -
A Comparative Study Between Bakri Balloon and B Lynch Suture Used to Control Primary Postpartum Hemorrhage After Cesarean Section
|
N/A | |
Not yet recruiting |
NCT03463070 -
Misoprostol Before and After Cesarean Section
|
Phase 3 | |
Recruiting |
NCT05532215 -
Sublingual Misoprostol in Reduction of Caesarean Blood Loss
|
N/A |